Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the appointment of Joseph Scalia to its executive leadership team as Vice President of Commercial Sales and Marketing. In this role, he is responsible for the company's U.S. commercial operations.
"We are delighted to welcome Joseph to the Mitsubishi Tanabe team as we pursue our mission to positively impact the lives of people living with devastating diseases such as ALS," said Atsushi Fujimoto, President, MTPA. "He brings a wealth of experience launching rare treatments, leading teams and building strong organizations. The MTPA leadership team looks forward to Joseph's partnership as we expand our services and grow in the U.S."
Scalia joins MTPA from Bayer Healthcare, where he served as Vice President and Head of Cardiopulmonary Marketing. He brings with him more than 20 years of commercial experience in the pharmaceutical industry in sales, marketing, market access and business operations both in the U.S. and globally. His expertise covers a wide range of therapeutic areas, including rare and orphan diseases.